Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Uterine Polyp Forceps Market Research Report 2026
Global Uterine Polyp Forceps Market Research Report 2026
Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 116 Pages
Report ld: 6469161
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Uterine Polyp Forceps Market Size(US$)
CAGR 2026-2032
3.1%
Market Size,2032
USD 20.22
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 16.83 million
Market Forecast in 2032(Value)
US$ 20.22 million
CAGR
3.1%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Uterine Polyp Forceps market was valued at US$ 16.38 million in 2025 and is anticipated to reach US$ 20.22 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Uterine Polyp Forceps competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Uterine polyp forceps is a medical device used in gynecological treatment to remove polyps in the uterus. Uterine polyps are benign tumors located on the surface of the endometrium, usually due to excessive proliferation of endometrial tissue. Although uterine polyps are generally benign, they can cause menstrual abnormalities, infertility, or other gynecological problems, so they often require treatment or removal.
This report delivers a comprehensive overview of the global Uterine Polyp Forceps market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Uterine Polyp Forceps. The Uterine Polyp Forceps market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Uterine Polyp Forceps market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Uterine Polyp Forceps manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- CooperSurgical
- DTR Medical
- Integra LifeSciences
- Vernacare
- Surtex Instruments
- Sklar Corporation
- Bolton Surgical
- BR Surgical
- BD
- Surgical Holdings
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Straight
- Curved
Segment by Application
- Hospitals
- Clinics
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Uterine Polyp Forceps manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Uterine Polyp Forceps sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Uterine Polyp Forceps Market Overview
1.1 Product Definition
1.2 Uterine Polyp Forceps by Type
1.2.1 Global Uterine Polyp Forceps Market Value by Type: 2025 vs 2032
1.2.2 Straight
1.2.3 Curved
1.3 Uterine Polyp Forceps by Application
1.3.1 Global Uterine Polyp Forceps Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Uterine Polyp Forceps Market Size Estimates and Forecasts
1.4.1 Global Uterine Polyp Forceps Revenue 2021–2032
1.4.2 Global Uterine Polyp Forceps Sales 2021–2032
1.4.3 Global Uterine Polyp Forceps Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Uterine Polyp Forceps Market Competition by Manufacturers
2.1 Global Uterine Polyp Forceps Sales Market Share by Manufacturers (2021–2026)
2.2 Global Uterine Polyp Forceps Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Uterine Polyp Forceps Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Uterine Polyp Forceps, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Uterine Polyp Forceps, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Uterine Polyp Forceps, Product Types and Applications
2.7 Global Key Manufacturers of Uterine Polyp Forceps, Date of Entry into the Industry
2.8 Global Uterine Polyp Forceps Market Competitive Situation and Trends
2.8.1 Global Uterine Polyp Forceps Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Uterine Polyp Forceps Players Market Share by Revenue
2.8.3 Global Uterine Polyp Forceps Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Uterine Polyp Forceps Market Scenario by Region
3.1 Global Uterine Polyp Forceps Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Uterine Polyp Forceps Sales by Region: 2021–2032
3.2.1 Global Uterine Polyp Forceps Sales by Region: 2021–2026
3.2.2 Global Uterine Polyp Forceps Sales by Region: 2027–2032
3.3 Global Uterine Polyp Forceps Revenue by Region: 2021–2032
3.3.1 Global Uterine Polyp Forceps Revenue by Region: 2021–2026
3.3.2 Global Uterine Polyp Forceps Revenue by Region: 2027–2032
3.4 North America Uterine Polyp Forceps Market Facts & Figures by Country
3.4.1 North America Uterine Polyp Forceps Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Uterine Polyp Forceps Sales by Country (2021–2032)
3.4.3 North America Uterine Polyp Forceps Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Uterine Polyp Forceps Market Facts & Figures by Country
3.5.1 Europe Uterine Polyp Forceps Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Uterine Polyp Forceps Sales by Country (2021–2032)
3.5.3 Europe Uterine Polyp Forceps Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Uterine Polyp Forceps Market Facts & Figures by Region
3.6.1 Asia Pacific Uterine Polyp Forceps Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Uterine Polyp Forceps Sales by Region (2021–2032)
3.6.3 Asia Pacific Uterine Polyp Forceps Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Uterine Polyp Forceps Market Facts & Figures by Country
3.7.1 Latin America Uterine Polyp Forceps Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Uterine Polyp Forceps Sales by Country (2021–2032)
3.7.3 Latin America Uterine Polyp Forceps Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Uterine Polyp Forceps Market Facts & Figures by Country
3.8.1 Middle East and Africa Uterine Polyp Forceps Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Uterine Polyp Forceps Sales by Country (2021–2032)
3.8.3 Middle East and Africa Uterine Polyp Forceps Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Uterine Polyp Forceps Sales by Type (2021–2032)
4.1.1 Global Uterine Polyp Forceps Sales by Type (2021–2026)
4.1.2 Global Uterine Polyp Forceps Sales by Type (2027–2032)
4.1.3 Global Uterine Polyp Forceps Sales Market Share by Type (2021–2032)
4.2 Global Uterine Polyp Forceps Revenue by Type (2021–2032)
4.2.1 Global Uterine Polyp Forceps Revenue by Type (2021–2026)
4.2.2 Global Uterine Polyp Forceps Revenue by Type (2027–2032)
4.2.3 Global Uterine Polyp Forceps Revenue Market Share by Type (2021–2032)
4.3 Global Uterine Polyp Forceps Price by Type (2021–2032)
5 Segment by Application
5.1 Global Uterine Polyp Forceps Sales by Application (2021–2032)
5.1.1 Global Uterine Polyp Forceps Sales by Application (2021–2026)
5.1.2 Global Uterine Polyp Forceps Sales by Application (2027–2032)
5.1.3 Global Uterine Polyp Forceps Sales Market Share by Application (2021–2032)
5.2 Global Uterine Polyp Forceps Revenue by Application (2021–2032)
5.2.1 Global Uterine Polyp Forceps Revenue by Application (2021–2026)
5.2.2 Global Uterine Polyp Forceps Revenue by Application (2027–2032)
5.2.3 Global Uterine Polyp Forceps Revenue Market Share by Application (2021–2032)
5.3 Global Uterine Polyp Forceps Price by Application (2021–2032)
6 Key Companies Profiled
6.1 CooperSurgical
6.1.1 CooperSurgical Company Information
6.1.2 CooperSurgical Description and Business Overview
6.1.3 CooperSurgical Uterine Polyp Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 CooperSurgical Uterine Polyp Forceps Product Portfolio
6.1.5 CooperSurgical Recent Developments/Updates
6.2 DTR Medical
6.2.1 DTR Medical Company Information
6.2.2 DTR Medical Description and Business Overview
6.2.3 DTR Medical Uterine Polyp Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 DTR Medical Uterine Polyp Forceps Product Portfolio
6.2.5 DTR Medical Recent Developments/Updates
6.3 Integra LifeSciences
6.3.1 Integra LifeSciences Company Information
6.3.2 Integra LifeSciences Description and Business Overview
6.3.3 Integra LifeSciences Uterine Polyp Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Integra LifeSciences Uterine Polyp Forceps Product Portfolio
6.3.5 Integra LifeSciences Recent Developments/Updates
6.4 Vernacare
6.4.1 Vernacare Company Information
6.4.2 Vernacare Description and Business Overview
6.4.3 Vernacare Uterine Polyp Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Vernacare Uterine Polyp Forceps Product Portfolio
6.4.5 Vernacare Recent Developments/Updates
6.5 Surtex Instruments
6.5.1 Surtex Instruments Company Information
6.5.2 Surtex Instruments Description and Business Overview
6.5.3 Surtex Instruments Uterine Polyp Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Surtex Instruments Uterine Polyp Forceps Product Portfolio
6.5.5 Surtex Instruments Recent Developments/Updates
6.6 Sklar Corporation
6.6.1 Sklar Corporation Company Information
6.6.2 Sklar Corporation Description and Business Overview
6.6.3 Sklar Corporation Uterine Polyp Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sklar Corporation Uterine Polyp Forceps Product Portfolio
6.6.5 Sklar Corporation Recent Developments/Updates
6.7 Bolton Surgical
6.7.1 Bolton Surgical Company Information
6.7.2 Bolton Surgical Description and Business Overview
6.7.3 Bolton Surgical Uterine Polyp Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Bolton Surgical Uterine Polyp Forceps Product Portfolio
6.7.5 Bolton Surgical Recent Developments/Updates
6.8 BR Surgical
6.8.1 BR Surgical Company Information
6.8.2 BR Surgical Description and Business Overview
6.8.3 BR Surgical Uterine Polyp Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BR Surgical Uterine Polyp Forceps Product Portfolio
6.8.5 BR Surgical Recent Developments/Updates
6.9 BD
6.9.1 BD Company Information
6.9.2 BD Description and Business Overview
6.9.3 BD Uterine Polyp Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 BD Uterine Polyp Forceps Product Portfolio
6.9.5 BD Recent Developments/Updates
6.10 Surgical Holdings
6.10.1 Surgical Holdings Company Information
6.10.2 Surgical Holdings Description and Business Overview
6.10.3 Surgical Holdings Uterine Polyp Forceps Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Surgical Holdings Uterine Polyp Forceps Product Portfolio
6.10.5 Surgical Holdings Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Uterine Polyp Forceps Industry Chain Analysis
7.2 Uterine Polyp Forceps Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Uterine Polyp Forceps Production Mode & Process Analysis
7.4 Uterine Polyp Forceps Sales and Marketing
7.4.1 Uterine Polyp Forceps Sales Channels
7.4.2 Uterine Polyp Forceps Distributors
7.5 Uterine Polyp Forceps Customer Analysis
8 Uterine Polyp Forceps Market Dynamics
8.1 Uterine Polyp Forceps Industry Trends
8.2 Uterine Polyp Forceps Market Drivers
8.3 Uterine Polyp Forceps Market Challenges
8.4 Uterine Polyp Forceps Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Uterine Polyp Forceps Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Uterine Polyp Forceps Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Uterine Polyp Forceps Market Competitive Situation by Manufacturers in 2025
Table 4. Global Uterine Polyp Forceps Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Uterine Polyp Forceps Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Uterine Polyp Forceps Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Uterine Polyp Forceps Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Uterine Polyp Forceps Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Uterine Polyp Forceps, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Uterine Polyp Forceps, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Uterine Polyp Forceps, Product Types and Applications
Table 12. Global Key Manufacturers of Uterine Polyp Forceps, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Uterine Polyp Forceps Companies by Tier (Tier 1, Tier 2, Tier 3), based on Uterine Polyp Forceps Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Uterine Polyp Forceps Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Uterine Polyp Forceps Sales by Region (K Units), 2021–2026
Table 18. Global Uterine Polyp Forceps Sales Market Share by Region (2021–2026)
Table 19. Global Uterine Polyp Forceps Sales by Region (K Units), 2027–2032
Table 20. Global Uterine Polyp Forceps Sales Market Share by Region (2027–2032)
Table 21. Global Uterine Polyp Forceps Revenue by Region (US$ Million), 2021–2026
Table 22. Global Uterine Polyp Forceps Revenue Market Share by Region (2021–2026)
Table 23. Global Uterine Polyp Forceps Revenue by Region (US$ Million), 2027–2032
Table 24. Global Uterine Polyp Forceps Revenue Market Share by Region (2027–2032)
Table 25. North America Uterine Polyp Forceps Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Uterine Polyp Forceps Sales by Country (K Units), 2021–2026
Table 27. North America Uterine Polyp Forceps Sales by Country (K Units), 2027–2032
Table 28. North America Uterine Polyp Forceps Revenue by Country (US$ Million), 2021–2026
Table 29. North America Uterine Polyp Forceps Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Uterine Polyp Forceps Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Uterine Polyp Forceps Sales by Country (K Units), 2021–2026
Table 32. Europe Uterine Polyp Forceps Sales by Country (K Units), 2027–2032
Table 33. Europe Uterine Polyp Forceps Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Uterine Polyp Forceps Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Uterine Polyp Forceps Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Uterine Polyp Forceps Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Uterine Polyp Forceps Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Uterine Polyp Forceps Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Uterine Polyp Forceps Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Uterine Polyp Forceps Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Uterine Polyp Forceps Sales by Country (K Units), 2021–2026
Table 42. Latin America Uterine Polyp Forceps Sales by Country (K Units), 2027–2032
Table 43. Latin America Uterine Polyp Forceps Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Uterine Polyp Forceps Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Uterine Polyp Forceps Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Uterine Polyp Forceps Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Uterine Polyp Forceps Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Uterine Polyp Forceps Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Uterine Polyp Forceps Revenue by Country (US$ Million), 2027–2032
Table 50. Global Uterine Polyp Forceps Sales (K Units) by Type (2021–2026)
Table 51. Global Uterine Polyp Forceps Sales (K Units) by Type (2027–2032)
Table 52. Global Uterine Polyp Forceps Sales Market Share by Type (2021–2026)
Table 53. Global Uterine Polyp Forceps Sales Market Share by Type (2027–2032)
Table 54. Global Uterine Polyp Forceps Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Uterine Polyp Forceps Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Uterine Polyp Forceps Revenue Market Share by Type (2021–2026)
Table 57. Global Uterine Polyp Forceps Revenue Market Share by Type (2027–2032)
Table 58. Global Uterine Polyp Forceps Price (US$/Unit) by Type (2021–2026)
Table 59. Global Uterine Polyp Forceps Price (US$/Unit) by Type (2027–2032)
Table 60. Global Uterine Polyp Forceps Sales (K Units) by Application (2021–2026)
Table 61. Global Uterine Polyp Forceps Sales (K Units) by Application (2027–2032)
Table 62. Global Uterine Polyp Forceps Sales Market Share by Application (2021–2026)
Table 63. Global Uterine Polyp Forceps Sales Market Share by Application (2027–2032)
Table 64. Global Uterine Polyp Forceps Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Uterine Polyp Forceps Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Uterine Polyp Forceps Revenue Market Share by Application (2021–2026)
Table 67. Global Uterine Polyp Forceps Revenue Market Share by Application (2027–2032)
Table 68. Global Uterine Polyp Forceps Price (US$/Unit) by Application (2021–2026)
Table 69. Global Uterine Polyp Forceps Price (US$/Unit) by Application (2027–2032)
Table 70. CooperSurgical Company Information
Table 71. CooperSurgical Description and Business Overview
Table 72. CooperSurgical Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. CooperSurgical Uterine Polyp Forceps Product
Table 74. CooperSurgical Recent Developments/Updates
Table 75. DTR Medical Company Information
Table 76. DTR Medical Description and Business Overview
Table 77. DTR Medical Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. DTR Medical Uterine Polyp Forceps Product
Table 79. DTR Medical Recent Developments/Updates
Table 80. Integra LifeSciences Company Information
Table 81. Integra LifeSciences Description and Business Overview
Table 82. Integra LifeSciences Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Integra LifeSciences Uterine Polyp Forceps Product
Table 84. Integra LifeSciences Recent Developments/Updates
Table 85. Vernacare Company Information
Table 86. Vernacare Description and Business Overview
Table 87. Vernacare Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Vernacare Uterine Polyp Forceps Product
Table 89. Vernacare Recent Developments/Updates
Table 90. Surtex Instruments Company Information
Table 91. Surtex Instruments Description and Business Overview
Table 92. Surtex Instruments Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Surtex Instruments Uterine Polyp Forceps Product
Table 94. Surtex Instruments Recent Developments/Updates
Table 95. Sklar Corporation Company Information
Table 96. Sklar Corporation Description and Business Overview
Table 97. Sklar Corporation Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Sklar Corporation Uterine Polyp Forceps Product
Table 99. Sklar Corporation Recent Developments/Updates
Table 100. Bolton Surgical Company Information
Table 101. Bolton Surgical Description and Business Overview
Table 102. Bolton Surgical Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Bolton Surgical Uterine Polyp Forceps Product
Table 104. Bolton Surgical Recent Developments/Updates
Table 105. BR Surgical Company Information
Table 106. BR Surgical Description and Business Overview
Table 107. BR Surgical Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. BR Surgical Uterine Polyp Forceps Product
Table 109. BR Surgical Recent Developments/Updates
Table 110. BD Company Information
Table 111. BD Description and Business Overview
Table 112. BD Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. BD Uterine Polyp Forceps Product
Table 114. BD Recent Developments/Updates
Table 115. Surgical Holdings Company Information
Table 116. Surgical Holdings Description and Business Overview
Table 117. Surgical Holdings Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Surgical Holdings Uterine Polyp Forceps Product
Table 119. Surgical Holdings Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Uterine Polyp Forceps Distributors List
Table 123. Uterine Polyp Forceps Customers List
Table 124. Uterine Polyp Forceps Market Trends
Table 125. Uterine Polyp Forceps Market Drivers
Table 126. Uterine Polyp Forceps Market Challenges
Table 127. Uterine Polyp Forceps Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Uterine Polyp Forceps
Figure 2. Global Uterine Polyp Forceps Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Uterine Polyp Forceps Market Share by Type: 2025 & 2032
Figure 4. Straight Product Picture
Figure 5. Curved Product Picture
Figure 6. Global Uterine Polyp Forceps Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Uterine Polyp Forceps Market Share by Application: 2025 & 2032
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Global Uterine Polyp Forceps Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Uterine Polyp Forceps Market Size (US$ Million), 2021–2032
Figure 12. Global Uterine Polyp Forceps Sales (K Units), 2021–2032
Figure 13. Global Uterine Polyp Forceps Average Price (US$/Unit), 2021–2032
Figure 14. Uterine Polyp Forceps Report Years Considered
Figure 15. Uterine Polyp Forceps Sales Share by Manufacturers in 2025
Figure 16. Global Uterine Polyp Forceps Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Uterine Polyp Forceps Players: Market Share by Revenue in Uterine Polyp Forceps in 2025
Figure 18. Uterine Polyp Forceps Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Uterine Polyp Forceps Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Uterine Polyp Forceps Sales Market Share by Country (2021–2032)
Figure 21. North America Uterine Polyp Forceps Revenue Market Share by Country (2021–2032)
Figure 22. U.S. Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Uterine Polyp Forceps Sales Market Share by Country (2021–2032)
Figure 25. Europe Uterine Polyp Forceps Revenue Market Share by Country (2021–2032)
Figure 26. Germany Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Uterine Polyp Forceps Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Uterine Polyp Forceps Revenue Market Share by Region (2021–2032)
Figure 33. China Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Taiwan Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Indonesia Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Thailand Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Malaysia Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Philippines Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Uterine Polyp Forceps Sales Market Share by Country (2021–2032)
Figure 44. Latin America Uterine Polyp Forceps Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Uterine Polyp Forceps Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Uterine Polyp Forceps Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. U.A.E Uterine Polyp Forceps Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Uterine Polyp Forceps by Type (2021–2032)
Figure 54. Global Revenue Market Share of Uterine Polyp Forceps by Type (2021–2032)
Figure 55. Global Uterine Polyp Forceps Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Uterine Polyp Forceps by Application (2021–2032)
Figure 57. Global Revenue Market Share of Uterine Polyp Forceps by Application (2021–2032)
Figure 58. Global Uterine Polyp Forceps Price (US$/Unit) by Application (2021–2032)
Figure 59. Uterine Polyp Forceps Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Uterine Polyp Forceps market size from 2026 to 2032?
The annual compound growth rate of the global Uterine Polyp Forceps market is 3.1% 2026 to 2032.
What was the global market size of Uterine Polyp Forceps in 2026?
What was the global market size of Uterine Polyp Forceps in 2032?
Which companies rank high in the global Uterine Polyp Forceps market?
Which region is expected to have the highest market share?
Related Reports
Uterine Polyp Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Uterine Polyp Forceps was estimated to be worth US$ 16.38 million in 2025 and is projected to reach US$ 20.22 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 129
USD 3950.00
(Single User License)
Global Uterine Polyp Forceps Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Uterine Polyp Forceps market size was US$ 15.9 million in 2024 and is forecast to a readjusted size of US$ 19.7 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 76
USD 4250.00
(Single User License)
Global Uterine Polyp Forceps Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Uterine Polyp Forceps market is projected to grow from US$ 15.9 million in 2024 to US$ 19.7 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 144
USD 4900.00
(Single User License)
Global Uterine Polyp Forceps Market Research Report 2025
The global market for Uterine Polyp Forceps was valued at US$ 15.9 million in the year 2024 and is projected to reach a revised size of US$ 19.7 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-01-16
Pages: 81
USD 2900.00
(Single User License)
Uterine Polyp Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Uterine Polyp Forceps was estimated to be worth US$ 15.9 million in 2024 and is forecast to a readjusted size of US$ 19.7 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 102
USD 3950.00
(Single User License)
Global Uterine Polyp Forceps Market Insights, Forecast to 2030
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published Date: 2024-04-12
Pages: 105
USD 4900.00
(Single User License)
Global Uterine Polyp Forceps Market Research Report 2024
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published Date: 2024-01-17
Pages: 93
USD 2900.00
(Single User License)
Uterine Polyp Forceps - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published Date: 2024-01-10
Pages: 123
USD 3950.00
(Single User License)
Uterine Polyp Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Uterine Polyp Forceps was estimated to be worth US$ 16.38 million in 2025 and is projected to reach US$ 20.22 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-06-16
Pages: 129
USD 3950.00 (Single User License)Global Uterine Polyp Forceps Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Uterine Polyp Forceps market size was US$ 15.9 million in 2024 and is forecast to a readjusted size of US$ 19.7 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 76
USD 4250.00 (Single User License)Global Uterine Polyp Forceps Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Uterine Polyp Forceps market is projected to grow from US$ 15.9 million in 2024 to US$ 19.7 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 144
USD 4900.00 (Single User License)Global Uterine Polyp Forceps Market Research Report 2025
The global market for Uterine Polyp Forceps was valued at US$ 15.9 million in the year 2024 and is projected to reach a revised size of US$ 19.7 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-01-16
Pages: 81
USD 2900.00 (Single User License)Uterine Polyp Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Uterine Polyp Forceps was estimated to be worth US$ 15.9 million in 2024 and is forecast to a readjusted size of US$ 19.7 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 102
USD 3950.00 (Single User License)Global Uterine Polyp Forceps Market Insights, Forecast to 2030
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published: 2024-04-12
Pages: 105
USD 4900.00 (Single User License)Global Uterine Polyp Forceps Market Research Report 2024
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published: 2024-01-17
Pages: 93
USD 2900.00 (Single User License)Uterine Polyp Forceps - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published: 2024-01-10
Pages: 123
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now